Ads
related to: can liver cancer be detected by a blood test interpretation chart for patients- uHCC Treatment Option
Patients: Learn More About A
Hepatocellular Carcinoma Treatment.
- Plan for uHCC Treatment
Diagnosis Can Be A Shock. Learn
How To Prepare For uHCC Treatment.
- uHCC Patient Information
Recently Diagnosed With uHCC?
Learn More About A Treatment Option
- uHCC Treatment Website
Visit Patients & Caregiver Site
To Learn About A Treatment Option.
- Patient & Caregiver Info
Learn More About uHCC & A
Treatment Option That Could Help.
- Talk To Your Doctor
Learn How To Start The Conversation
About A uHCC Treatment Option.
- uHCC Treatment Option
Search results
Results From The WOW.Com Content Network
FibroTest, known as FibroSure in the US, is a biomarker test that uses the results of six blood serum tests to generate a score that is correlated with the degree of liver damage in people with a variety of liver diseases. FibroTest has the same prognostic value as a liver biopsy.
Liver function tests (LFTs or LFs), also referred to as a hepatic panel or liver panel, are groups of blood tests that provide information about the state of a patient's liver. [1] These tests include prothrombin time (PT/INR), activated partial thromboplastin time (aPTT), albumin , bilirubin (direct and indirect), and others.
The Liver Imaging Reporting and Data System (aka LI-RADS) is a quality assurance tool created and trademarked by the American College of Radiology in 2011 to standardize the reporting and data collection of CT and MR imaging patients at risk for hepatocellular carcinoma (HCC), or primary cancer of the liver cells. [1]
Liver cancer can be primary in which the cancer starts in the liver, or it can be liver metastasis, or secondary, in which the cancer spreads from elsewhere in the body to the liver. Liver metastasis is the more common of the two liver cancers. [3] Instances of liver cancer are increasing globally. [8] [9]
High levels of alpha-fetoprotein (AFP) in the blood can be found in many cases of HCC and intrahepatic cholangiocarcinoma. Cholangiocarcinoma can be detected with these commonly used tumor markers: carbohydrate antigen 19-9 (CA 19–9), carcinoembryonic antigen (CEA) and cancer antigen 125 . These tumour markers are found in primary liver ...
Liver biopsy is often required for the diagnosis of a liver problem (jaundice, abnormal blood tests) where blood tests, such as hepatitis A serology, have not been able to identify a cause. It is also required if hepatitis is possibly the result of medication , but the exact nature of the reaction is unclear.
Ads
related to: can liver cancer be detected by a blood test interpretation chart for patients